Oral anticoagulant monotherapy in patients with chronic coronary disease: An updated meta-analysis
The American Journal of Medicine
•
February 01, 2026
Anticoagulant alone lowers bleeding without harm
In chronic coronary disease needing long-term anticoagulation, anticoagulant-only treatment reduced bleeding without increasing heart attack, stroke, or death versus adding one antiplatelet drug. *Systematic review and meta-analysis of randomized trials; Level 1a (OCEBM).
- Level of evidence
- Level 1a (OCEBM)
- DocG quality score
- 8.2 / 10
Read the full summary free
Patients, intervention, outcomes, results, and clinical applicability in about 300 words — plus new summaries in your inbox 3× per week.
Sign in with Google
